![]() |
产地 | 中国 |
品牌 | 爱必信(absin) |
货号 | abs812188 |
用途 | 见爱必信官网 |
英文名称 | 见爱必信官网 |
包装规格 | 5mg,5mg,25mg,25mg |
纯度 | ≥98%% |
CAS编号 | 130663-39-7 |
别名 | PD123319; PD-123319; (S)-(+)-PD 123319 |
是否进口 | 否 |
公告提醒:爱必信所有产品和服务仅用于科学研究,不用于临床应用及其他用途提供产品和服务(也不为任何个人提供产品和服务)!
抑制剂描述: 产品名称:PD123319 产品别名:见爱必信官网 英文别名:PD123319 靶点:Angiotensin Receptor CAS:130663-39-7 纯度:≥98% 外观:见爱必信官网 保存方法:Store at -20℃ for one year(Powder);Store at 2-4℃ for two weeks;Store at -20℃ for six months after dissolution. 描述: PD123319是一种有效的,选择性AT2血管紧张素Ⅱ受体拮抗剂, IC50为34 nM。 溶解性:DMSO :100 mg/mL (196.61 mM) 体外研究:
PD 123319 is shown to discriminate between two subclasses of AII receptors in many different tissues. 125I-AII specifically labeled two classes of binding sites for AII in a membrane preparation of bovine adrenal glomerulosa cells. The first class (DuP-753 sensitive) represents approximately 85% of the total binding sites for AII and possesses a high affinity (IC50 of 92.9 nM) for DuP-753. PD-123319 does not have any effect on 125I-AII binding to this site. The second class of binding sites is more sensitive to PD-123319, with an IC50 of 6.9 nM, and has a much lower affinity for DuP-753 (IC50 around 10 microM). 体内研究:PD 123319 has no effect on cerebral blood flow autoregulation. Acute AT2-receptor blockade does not influence CBF autoregulation. Intravenous administration of PD 123319 to conscious hypertensive rats elicites an immediate dose-dependent increase in MAP that is sustained for approximately 7.4 min with 3 mg/kg PD 123319.
产品信息订购:
|